- Home
- GDHG vs CLRB Comparison
GDHG vs CLRB Comparison
Compare GDHG & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDHG
- CLRB
- Stock Information
- Founded
- GDHG 2008
- CLRB 2002
- Country
- GDHG China
- CLRB United States
- Employees
- GDHG N/A
- CLRB N/A
- Industry
- GDHG Services-Misc. Amusement & Recreation
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- GDHG Consumer Discretionary
- CLRB Health Care
- Exchange
- GDHG Nasdaq
- CLRB Nasdaq
- Market Cap
- GDHG 9.0M
- CLRB 10.7M
- IPO Year
- GDHG 2023
- CLRB N/A
- Fundamental
- Price
- GDHG $2.41
- CLRB $0.25
- Analyst Decision
- GDHG
- CLRB Buy
- Analyst Count
- GDHG 0
- CLRB 2
- Target Price
- GDHG N/A
- CLRB $28.00
- AVG Volume (30 Days)
- GDHG 444.2K
- CLRB 3.1M
- Earning Date
- GDHG 02-13-2025
- CLRB 11-18-2024
- Dividend Yield
- GDHG N/A
- CLRB N/A
- EPS Growth
- GDHG N/A
- CLRB N/A
- EPS
- GDHG 1.62
- CLRB N/A
- Revenue
- GDHG $25,549,903.00
- CLRB N/A
- Revenue This Year
- GDHG N/A
- CLRB N/A
- Revenue Next Year
- GDHG N/A
- CLRB N/A
- P/E Ratio
- GDHG $1.47
- CLRB N/A
- Revenue Growth
- GDHG N/A
- CLRB N/A
- 52 Week Low
- GDHG $1.14
- CLRB $0.22
- 52 Week High
- GDHG $42.35
- CLRB $4.45
- Technical
- Relative Strength Index (RSI)
- GDHG 56.46
- CLRB 19.90
- Support Level
- GDHG $1.98
- CLRB $0.23
- Resistance Level
- GDHG $2.84
- CLRB $0.33
- Average True Range (ATR)
- GDHG 0.34
- CLRB 0.03
- MACD
- GDHG -0.03
- CLRB 0.04
- Stochastic Oscillator
- GDHG 70.95
- CLRB 13.08
About GDHG Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.